Readers hoping to buy Concentra Group Holdings Parent, Inc. ( NYSE:CON ) for its dividend will need to make their ...

Concentra Group Holdings Parent, Inc. (CON) Q1 2026 Management view CEO William Newton said the company had “a strong start to the year,” reporting “Total company revenue was $569.6 million in Q1 2026 ...

a) Record Date: The record date for the spin-off is November 18, 2024. b) Split Ratio: Shareholders will receive approximately 0.806971 shares of Concentra’s common stock for each share of Select ...

Concentra Group Holdings Parent, Inc. reported past first-quarter 2026 results with sales of US$569.56 million and net income of US$50.49 million, raised its full-year 2026 revenue and earnings ...

ADDISON, Texas--(BUSINESS WIRE)--Concentra ® Group Holdings Parent, Inc. (“Concentra”) (NYSE: CON) will release the financial results for its first quarter ended March 31, 2026, on Thursday, May 7, ...

Concentra Group Holdings Parent, Inc. ( CON) Q1 2026 Earnings Call May 8, 2026 9:00 AM EDT ...

Tang Capital Partners’ Concentra Biosciences is back with yet another biotech buyout offer, this time proposing to acquire LianBio in a cash deal of $4.30 per share. Part of the offer includes ...

Concentra demonstrates dominant market positioning, leveraging scale and integration with major employers to achieve consistent double-digit revenue and EBITDA growth. Preliminary 2025 results show 13 ...

Days after picking up IGM Biosciences, serial biotech acquirer Concentra Biosciences has secured another company in the form of cash-strapped Cargo Therapeutics. The deal will see Tang Capital ...

CAR-T therapy developer CARGO Therapeutics has found a way forward after abandoning its clinical programmes and slashing staff to the bone earlier this year: a merger with Concentra Biosciences.

Last spring, a doctor for Concentra Inc., the leading US occupational health-care company, told his boss he wanted to quit. The workload of as many as 40 patients a day was too great, and the breaks ...